Palifosfamide, the active moiety of ifosfamide (IFOS), is a bi-functional alkylator that causes irreparable inter-strand DNA cross-linking, resulting in cell death. Palifosfamide is equal to or more active
The SEEplate cervical plate system incorporates features that are aimed at allowing surgeons an alternative to confirming the secure placement of the anti-back-out mechanism of screws used as
As a result of the acquisition, GlaxoSmithKline (GSK) will become the leading pharmaceutical company in Egypt with a market share of approximately 9%. GSK will acquire 20 branded
Following the recommendation for regulatory approval under the European decentralized procedure, Toctino received national regulatory approval in Finland. Following the regulatory approval of Toctino in Finland, Basilea will
In addition to their appointments to the board, Mr Benjamin has been appointed to serve on the company’s audit committee, and Mr Meyer has been appointed to serve
Amadeus is being developed as a four-armed robotic surgical system that combines aerospace, medical and defense technologies. The Phase B prototype includes improvements in vision system, force feedback,
The rights to this patent and related proprietary technology, the neuNanoParticle, have been obtained by neuMirRx Corp through an exclusive license arrangement with Formatech of Andover, Massachusetts. According
The US Court of Appeals for the Federal Circuit has reportedly affirmed the ruling by the US District Court of New York. The source has also cited a
Qlaira is an oral contraceptive whose estrogen component is based on estradiol, the same estrogen that is produced by the female body. With Qlaira, Bayer Schering Pharma offers
According to the company, polyetheretherketone (PEEK) polymer, a biomaterial widely accepted for spinal applications, provides several benefits such as biocompatibility and radiolucency (allows the passage of X-rays). The
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.